Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Clinica Baviera (D9Z) AI Stock Analysis

DE:D9Z

Clinica Baviera

(Frankfurt:D9Z)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Steady Revenue GrowthThe sustained increase in revenue indicates expanding demand for Clinica Baviera’s ophthalmology services across its clinic network. Continued top-line growth supports operating leverage, provides resources for clinic investment, and strengthens the company’s ability to compound earnings over the next several quarters.
Negative Factors
Margin VolatilityRecent changes in gross and operating margins introduce uncertainty around how durable the company’s current profitability is. If the movement reflects cost or pricing pressure rather than temporary mix effects, continued margin volatility could limit earnings growth even while revenue remains positive.

Clinica Baviera (D9Z) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%60%DE:D9Z+32.37%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 867.34M
Dividend Yield
3.00%
Average Volume (3M)
21
Price to Earnings (P/E)
19.0
Beta (1Y)
0.69
Revenue Growth
10.89%
EPS Growth
17.12%
Country
Germany
Employees
2,009
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Clinica Baviera Business Overview & Revenue Model

Company Description

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pedi...

Clinica Baviera Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:D9Z against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ES:ALMES:ALM65NeutralEUR 2.31B32.004.78%1.74%9.67%174.00%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%20%40%DE:D9ZES:ALMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:D9Z and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:D9ZClinica Baviera53.4012.4730.47%
ES:ALMAlmirall SA10.60-1.34-11.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.